Fig. 9From: Advanced extracellular vesicle bioinformatic nanomaterials: from enrichment, decoding to clinical diagnosticsComponent of microfluidic platform and analysis of clinical samples. (A) Microfluidic platform structure. (B) Changes in mRNA levels in longitudinal EV associated with clinical assessments. (C) Changes in EVs mRNA levels in GMB patients after TMZ treatmentBack to article page